TrialLancet (London, England)2011

Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study.

Sebahattin Cirak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.